OMCM News Prominent Biotech Company Awards OmniC
Post# of 144503
OMCM News Prominent Biotech Company Awards OmniComm Systems Large Phase III Contract
2012-04-25 08:45 ET - News Release
FORT LAUDERDALE, FL -- (Marketwire) -- 04/25/12
OmniComm Systems, Inc. (OTCBB: OMCM), one of the fastest growing companies in the EDC marketplace today, announced that its TrialMaster® suite of applications and Interactive Web Response (IWR) solution has been chosen by this US-based biotechnology company to manage the clinical data management needs for this 2 year, 700+ subject, multi-national trial with over 60 sites across 6 countries.
"This large complex clinical trial is actually a follow-on study," said Stephen Johnson, President & COO of OmniComm. "We are very pleased that this biotech company has once again trusted us for such an important study. It speaks volumes to the level of support that we've provided thus far."
OmniComm will be designing and hosting this study and randomization of patients will be done through its web-based IWR solution. The study design will deploy CDISC standards for CDASH and SDTM to facilitate rapid data collection, processing and exporting of study data. OmniComm's world-class help desk, offering support in 14 different languages, will also be instrumental in ensuring a successful trial.
(0)
(0)